Other medical applications
The special physical and chemical nature of PRASINOGUARD has an exciting, but not fully explored, potential in medical device products. The high level of purity and the controlled production process make it more appropriate in medical products compared to similar products captured in the wild.
The polysaccharide consists of common sugar subunits, such as glucose and galactose, which are found in all natural carbohydrates. These are combined in a unique polymer with a high degree of sulphation. Sulphated polysaccharides like PRASINOGUARD are well known for their anti-viral properties. The extreme high molecular weight with its sheer-thinning viscosity creates unique end use possibilities.
There are multiple end-uses opportunities for this novel product based on academic studies, molecular properties and customer feedback:
- Wound care
- Eye care
- Feminine care
- Anti-viral applications
- Drug delivery and microencapsulation
- Anti-inflammatory properties
- Medical 3D-printing
MicroA cultivates P. capsulatus using cold Norwegian coastal water and MicroA patented technology to ensure a controlled, stable and safe production. The refinement of PRASINOGUARD into a finished product is a gentle chemical-free process performed in-house that includes physical separation, concentration and drying. The only by-product from the process are natural seawater and the algae cells.
The ingredient has been shown to be safe in humans (HRIPT) and in a wide range of in vitro systems. PRASINOGUARD is a non-GMO product.
Prasinoguard can be provided as a concentrated solution, or as spray or freeze dried product, depending on the end use of the product. The product can also be depolymerised upon request. The product is white in dried condition with no additional treatment needed.
INCI: Prasinococcus capsulatus Exopolysaccharide
Please contact us for background data, technical specification, pricing and availability.